| First half expectations exceeded at BioProgress |
| Written by Business Weekly | |
| Tuesday, 19 June 2007 | |
|
Specialty pharmaceutical firm, BioProgress has announced above-expectation results for the first half and said it is confident of maintaining the progress for the rest of the year.
The Cambridge-based firm highlighted a move into female healthcare products through a new partnership with Merck Serono, adding that it is in discussions with 15 other pharmaceuticals for partnering arrangements. It also said that it is launching a new topical treatment for cellulite, to corner a share of the £15m UK market along with the growing European market. Shares in BioProgress have grown almost five per cent, rising 2.75p to 62.5p. |
| < Prev | Next > |
|---|